Oncología Traslacional
ONCTRAS
Catholic University of the Sacred Heart
Milán, ItaliaPublications en collaboration avec des chercheurs de Catholic University of the Sacred Heart (15)
2024
-
Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial
International Journal of Gynecological Cancer
2023
-
Best original research presented at the 24th European Congress on Gynaecological Oncology—Best of ESGO 2023
International Journal of Gynecological Cancer, Vol. 34, Núm. 4, pp. 610-618
-
Editorial: Lymph node assessment in cervical cancer
Frontiers in Oncology
-
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
Annals of Oncology, Vol. 34, Núm. 10, pp. 833-848
-
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
Annals of Oncology, Vol. 34, Núm. 8, pp. 681-692
-
Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
European Journal of Cancer, Vol. 189
2022
-
SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer
International Journal of Gynecological Cancer, Vol. 32, Núm. 10, pp. 1236-1243
2021
-
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
International Journal of Gynecological Cancer, Vol. 31, Núm. 7, pp. 961-982
-
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors
Ultrasound in Obstetrics and Gynecology
-
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours
FACTS VIEWS AND VISION IN OBGYN, Vol. 13, Núm. 2, pp. 107-130
-
European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery
International Journal of Gynecological Cancer, Vol. 31, Núm. 9, pp. 1199-1206
-
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 12, pp. 1721-1731
-
Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study
Gynecologic Oncology, Vol. 162, Núm. 3, pp. 590-598
2014
2013
-
Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer
European Journal of Cancer, Vol. 49, Núm. 18, pp. 3831-3838